Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hi Chesh (and assuming you are still talking to me of course),
Seen the latest tweet from our partners at MSYS re China?
We are entering "Therapeutic Drug Monitoring" (TDM). Our technology will be used patient-side, initially for psychotropic therapy monitoring in China. Read this blog, describing TDM & how we are transforming point of care therapeutics.
#msys #poct #TDM
BTW and at the risk of offending some on here, this was my BUY today, reported as a sell fwiw.
23-Jun-21 09:55:52 32.74 16,768 Sell* 32.00 33.50 5,490
Diversified,
Getting our new 30p investor who will be taking several £m value of new shares is just the start of things and that deal has sealed it for me. AS TB once said, things can only get better!
N - It certainly has a lot going for it, the chart TA looks ripe to rip.
I continue to read and learn, it would appear to me that the current shareholder register is frustrated by pace of disclosed progress. For me the institutions will arrive in significant numbers if all falls into place, and certainly if revenue for 2021 increases at a pace anywhere near to what some have suggested on here. All seems up for grabs.
Diversified, That's what we have been saying here for a while now. Anyone of these divisions could deliver spectacular growth alone, if all of them deliver then who knows how big this could be.
It’s interesting that he made reference in June 2020 to a business model that he had used in a previous company of his that was able to increase turnover from 5/35m within two years by actively partnering with others which in turn reduced capex and took advantage of other companies distribution channels.
You can see the volume/capacity from the China Resources deal that would take the Wastewater monitoring arm to another level and allow for the widely touted deals in Europe as part of a wider expansion via an OEM. It’s first major deal would then prove to others it’s immediate value and would facilitate a rapid growth in deals.
It has taken me a while to get my head around what appears to be the commercialization roadmap, but it’s all their to be pieced together.
If this turns out to be anything like what I think it could, today’s market cap is simply ludicrous and presents a unique proposition.
I was looking at a revised figure of £20M Diversified. GB has been very bullish about China Resources as other posters have highlighted. The devil, they say, is in the detail so waiting to scrutinise the detail might be in order. As GB has stated, managing shareholder expectation is extremely difficult so it must be a nightmare for him at the moment with the newsflow that is due.
Diversified,
Absolutely, looking for a figure @£15m but possibly up to £20m.
Is anyone expecting an upwards revision to 2021 £10m revenue guidance on Monday?
I expect forward guidance to be revised based on likely progress with China Resources with a conservative caveat implying that this is dependent on completion of the deal.
I can’t see why the CEO would tweet about the chambers of commerce if Gerard and Linian LI were not confident of progress towards the 30th June implied target date.
Can't even get a quote for £25...wtf?
I have no doubt that the recent placing has strengthened what is a predominately private shareholder register. Management and new institutions in the recent placing will be invested over a longer time frame.
Volume is by no means significant which in turn reduces liquidity and increases volatility. It will be newsflow that ultimately drives this share price.
Take advantage of the dips if you believe in the fundamentals. It may of taken some time to hit the commercial end of the newsflow that will reinvigorate interest, but I see no reason to disbelieve the imminent timetable.